Licensing Agreements
CureMark and Balchem sign licensing and development agreement for enzyme specialty products
Published in Gene Therapy Weekly, December 14th, 2006
Under the agreement, Balchem has granted CureMark an exclusive license for using its patented and proprietary drug delivery technology, PharmaShure in all of CureMark's digestive/pancreatic enzyme products. CureMark has found that autistic children suffer from a pancreatic secretory deficiency and has demonstrated in empirical studies that a specific pancreatic enzyme formulation can positively impact many aspects of autism.
"This is a major step in our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-14)
More Articles from Gene Therapy Weekly
- Genetics & Genomics
Gene therapy technique to combat alpha-1 antitrypsin disorder proves safe and effective - Angiogenesis
Data from Konyang University, College of Medicine provide new insights into angiogenesis - Angiogenesis
Reports outline angiogenesis study findings from Toho University, Center of Diabetes - Colon Cancer
Researchers from Integrated Cancer Prevention Center detail findings in colon cancer - Dengue Fever
Data from Rush University advance knowledge in dengue fever - DNA Vaccines
Researchers from Huazhong Agricultural University, College of Veterinary Medicine publish findings in DNA vaccines - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
